PharmaResearch Co Ltd 214450
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₩314,500.00
- Day Range
- ₩311,500.00–325,500.00
- 52-Week Range
- ₩255,000.00–606,000.00
- Bid/Ask
- ₩312,500.00 / ₩313,000.00
- Shares Outstanding
- 10.39M
- Market Cap
- ₩3.25T
- Volume/Avg
- 38,863 / 166,852
Key Statistics
- Price/Earnings (Normalized)
- 19.62
- Price/Sales
- 6.33
- Dividend Yield (Trailing)
- 1.18%
- Dividend Yield (Forward)
- 1.18%
- Dividend Payment Schedule
- Apr
- Total Yield
- 1.18%
Company Profile
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 470
- Website
- http://www.pr-products.co.kr
Valuation
|
Metric
|
214450
|
|---|---|
Price/Earnings (Normalized) | 19.62 |
Price/Book Value | 4.34 |
Price/Sales | 6.33 |
Price/Cash Flow | 17.03 |
Price/Earnings
214450
Financial Strength
|
Metric
|
214450
|
|---|---|
Quick Ratio | 6.65 |
Current Ratio | 7.72 |
Interest Coverage | 24.06 |
Quick Ratio
214450
Profitability
|
Metric
|
214450
|
|---|---|
Return on Assets (Normalized) | 18.45% |
Return on Equity (Normalized) | 27.61% |
Return on Invested Capital (Normalized) | 25.18% |
Return on Assets
214450
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|x>fPf?? | LOCK|@hmf | $128B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|J?hDd<n | LOCK|kH&M | $76B | |||
| Moderna Inc
MRNA
| LOCK|N$k&$GR | LOCK|CF | $75B | |||
| argenx SE ADR
ARGX
| LOCK|TcTG&$ | LOCK|qs | $60B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|CCGDZP& | LOCK|z&< | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|tqV>t#$ | LOCK|<WV#J | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^k>@tHlt | LOCK|Pz^# | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|Q<LhdK | LOCK|q?B | $24B | |||
| Incyte Corp
INCY
| LOCK|TS%W%? | LOCK|js^ | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|x<SV?c< | LOCK|l> | $15B |
United States